小方制药
(603207)
| 流通市值：10.58亿 | | | 总市值：43.18亿 |
| 流通股本：3919.78万 | | | 总股本：1.60亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 367,213,945.74 | 261,788,742.56 | 471,871,615.15 | 367,014,216.77 |
| 营业收入 | 367,213,945.74 | 261,788,742.56 | 471,871,615.15 | 367,014,216.77 |
| 二、营业总成本 | 179,224,454.99 | 122,116,783.78 | 240,789,017.91 | 174,327,199.42 |
| 营业成本 | 125,382,134.24 | 87,539,532.01 | 162,970,922.24 | 125,114,665.74 |
| 税金及附加 | 2,664,580.51 | 2,081,413.52 | 3,534,365.63 | 2,872,040 |
| 销售费用 | 30,176,932.37 | 20,471,502.44 | 44,501,146.63 | 28,151,596.39 |
| 管理费用 | 12,391,414.28 | 7,162,358 | 14,971,263.37 | 10,760,671.1 |
| 研发费用 | 10,672,621.35 | 6,561,697.12 | 16,281,098.95 | 7,822,976.91 |
| 财务费用 | -2,063,227.76 | -1,699,719.31 | -1,469,778.91 | -394,750.72 |
| 其中:利息费用 | 22,680.07 | 16,339.85 | 46,927.45 | 36,955.92 |
| 其中:利息收入 | -2,116,494.05 | -1,738,004.05 | -1,563,817.93 | -469,268 |
| 加:公允价值变动收益 | - | 15,584.9 | 55,137.4 | 41,388.63 |
| 加:投资收益 | 15,584.9 | - | 2,197,701.9 | 2,197,701.4 |
| 资产减值损失(新) | 49,200.85 | 37,154.74 | -97,611.58 | -132,978.42 |
| 信用减值损失(新) | -638,040.49 | -1,694,477.03 | -170,945.25 | -496,535.86 |
| 其他收益 | 1,665,052.33 | 1,213,222.86 | 3,113,034.79 | 1,973,015.42 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 189,081,288.34 | 139,243,444.25 | 236,179,914.5 | 196,269,608.52 |
| 加:营业外收入 | - | - | 1,000,037.56 | 1,000,037.56 |
| 减:营业外支出 | 310,077.11 | 310,054.1 | 10,000 | 10,000 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 188,771,211.23 | 138,933,390.15 | 237,169,952.06 | 197,259,646.08 |
| 减:所得税费用 | 27,101,723.92 | 20,117,459.32 | 33,542,924.4 | 28,731,686.17 |
| 六、净利润 | 161,669,487.31 | 118,815,930.83 | 203,627,027.66 | 168,527,959.91 |
| 持续经营净利润 | 161,669,487.31 | 118,815,930.83 | 203,627,027.66 | 168,527,959.91 |
| 归属于母公司股东的净利润 | 161,669,487.31 | 118,815,930.83 | 203,627,027.66 | 168,527,959.91 |
| (一)基本每股收益 | 1.28 | 0.99 | 1.7 | 1.4 |
| (二)稀释每股收益 | 1.28 | 0.99 | 1.7 | 1.4 |
| 九、综合收益总额 | 161,669,487.31 | 118,815,930.83 | 203,627,027.66 | 168,527,959.91 |
| 归属于母公司股东的综合收益总额 | 161,669,487.31 | 118,815,930.83 | 203,627,027.66 | 168,527,959.91 |
| 公告日期 | 2024-10-29 | 2024-08-07 | 2024-08-07 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |